Colinz Laboratories Intrinsic Value
Colinz Laboratories intrinsic value. Colinz Laboratories (COLINZ) median intrinsic value is ₹135.83 from 9 valuation models (range ₹60–₹219), vs current price ₹73.00 — +86.1% upside (Trading Below Calculated Value), margin of safety 46.3%. Read COLINZ dividend track record for the complete payout history and dividend yield track record.
COLINZ Valuation Methods Summary — DCF, Graham Number & P/E
Colinz Laboratories intrinsic value across 9 models vs current price ₹73.00 — upside/downside and value range per method. Compare with COLINZ fair value estimate to assess whether the stock is under or overvalued.
| Method | Type | Intrinsic Value | Range | Upside/Downside | Details |
|---|---|---|---|---|---|
| P/E Based Valuation | earnings | ₹219.00 | ₹175.20 - ₹262.80 | +200.0% | EPS: ₹11.10, Sector P/E: 22x |
| Book Value Method | asset | ₹66.67 | ₹60.00 - ₹73.34 | -8.7% | Book Value/Share: ₹33.33, P/B: 2.0x |
| Revenue Multiple Method | revenue | ₹60.00 | ₹54.00 - ₹66.00 | -17.8% | Revenue/Share: ₹30.00, P/S: 2.0x |
| EBITDA Multiple Method | earnings | ₹133.33 | ₹120.00 - ₹146.66 | +82.6% | EBITDA: ₹4.00Cr, EV/EBITDA: 10x |
| Simple DCF (5Y) | dcf | ₹135.83 | ₹108.66 - ₹163.00 | +86.1% | CF Growth: 15.0%, Discount: 15% |
| PEG Ratio Method | growth | ₹177.60 | ₹159.84 - ₹195.36 | +143.3% | EPS Growth: 20.0%, Fair P/E: 16.0x |
| Growth Adjusted P/E | growth | ₹171.90 | ₹154.71 - ₹189.09 | +135.5% | Revenue Growth: 6.5%, Adj P/E: 15.5x |
| ROE Based Valuation | profitability | ₹146.00 | ₹131.40 - ₹160.60 | +100.0% | ROE: 30.0%, P/E Multiple: 16x |
| Graham Defensive Method | conservative | ₹66.67 | ₹60.00 - ₹73.34 | -8.7% | EPS: ₹11.10, BVPS: ₹33.33 |
COLINZ Intrinsic Value vs Market Price — All Valuation Models
Colinz Laboratories fair value range ₹60–₹219 vs current market price ₹73.00 across 9 valuation models. For current market price and key ratios, visit Colinz Laboratories share price today.
COLINZ Intrinsic Value Analysis — Undervalued or Overvalued?
Colinz Laboratories median intrinsic value ₹135.83, current price ₹73.00 — Trading Below Calculated Value by 86.1%, margin of safety 46.3%.
What is the intrinsic value of COLINZ?
Based on our comprehensive analysis using 9 different valuation methods, the estimated intrinsic value of Colinz Laboratories (COLINZ) is ₹135.83 (median value). With the current market price of ₹73.00, this represents a +86.1% variance from our estimated fair value.
The valuation range spans from ₹60.00 to ₹219.00, indicating ₹60.00 - ₹219.00.
Is COLINZ undervalued or overvalued?
Based on our multi-method analysis, Colinz Laboratories (COLINZ) appears to be trading below calculated value by approximately 86.1%.
COLINZ Financial Health — Key Ratios vs Industry Benchmarks
Colinz Laboratories financial ratios — ROE, debt-to-equity, profit margins and liquidity vs industry benchmarks and their impact on intrinsic value.
| Financial Metric | Current Value | Industry Benchmark | Assessment | Impact on Valuation |
|---|---|---|---|---|
| Return on Equity | 30.0% | Industry Standard: 15%+ | Above 15% | Measures shareholder return efficiency |
| Operating Margin | 6.0% | Industry Standard: 20%+ | Below 10% | Indicates operational efficiency level |
| Asset Turnover Ratio | 0.69x | Industry Standard: 1.0x+ | Above 0.5x | Measures asset utilization efficiency |
COLINZ Cash Flow Quality — Operating & Free Cash Flow
Colinz Laboratories operating cash flow, free cash flow, quality rating and sustainability score by period — key inputs to DCF intrinsic value calculation.
| Period | Operating Cash Flow | Free Cash Flow | Cash Flow Quality | Sustainability Score |
|---|---|---|---|---|
| March 2026 | ₹3 Cr | ₹3 Cr | Positive Free Cash Flow | 8/10 |
| March 2025 | ₹-2 Cr | ₹-2 Cr | Negative Cash Flow | 3/10 |
| March 2024 | ₹1 Cr | ₹1 Cr | Positive Free Cash Flow | 8/10 |
| March 2023 | ₹0 Cr | ₹0 Cr | Negative Cash Flow | 3/10 |
| March 2022 | ₹1 Cr | ₹1 Cr | Positive Free Cash Flow | 8/10 |